Funding · 11 March 2026Genexis Biotech$457K+Recombinant protein production via fermentation
FundingHealthcare & Life Sciences
Genexis Biotech raises seed funding for protein platform
By Abha Lohia · Editor ·
seedFounded 2019-10
- Genexis Biotech uses precision fermentation to produce recombinant proteins for research and pharma
- It raised over $457K in seed funding and earlier got support from Indigram Labs Foundation
- The startup aims to localise production of specialised proteins currently imported into India at high cost
What happened
- Genexis Biotech is a deep-tech startup that uses advanced fermentation technologies to produce recombinant proteins.
- Its core technology is precision fermentation, using microorganisms like yeast and bacteria as biological factories.
- The company has worked on 15-20 proteins across different platforms.
- It raised over $457K in seed funding, with early support from Indigram Labs Foundation.
- Earlier funding came from personal savings and revenue from supplying proteins to government labs during the COVID-19 pandemic.
Why it matters
- The startup's fermentation yields are nearly 20 times higher than traditional industry benchmarks.
- Its success rate in protein development projects is 60-70%.
- Genexis aims to localise production of specialised proteins currently imported into India at high cost.
The business
- Genexis Biotech is a deep-tech startup focused on advanced fermentation technologies and recombinant protein production.
- Its core technology is precision fermentation, using microorganisms (yeast, bacteria, cell culture) as biological factories.
- The platform produces multiple recombinant proteins; it has worked on 15-20 proteins across platforms.
- Fermentation protein yields are nearly 20 times higher than traditional industry benchmarks.
- The company follows a market-driven innovation approach, identifying proteins with commercial demand and ethical value.
- It has a multi-tiered market strategy: Research Use Only proteins, GMP-grade for pharma, and regulatory-approved for global markets.
- The goal is to localise production of specialised proteins currently imported into India at high cost.
The founders
VK
Vipul Kumar
founder- Has over 15 years of experience in biotechnology.
- Worked at Biocon and a CRO (Contract Research Organisation).
DJ
Dr. Jitendra Wagh
co-founderWho put in money
- Indigram Labs Foundation existing — Early supporter that introduced the startup to deep-tech investors.
In numbers
$457K+Seed funding raised
20 times higherFermentation protein yields vs industry benchmarks
60-70%Success rate in protein development projects
15-20Number of proteins worked on
Words to know
- Precision fermentation
- Using microorganisms like yeast or bacteria as biological factories to produce specific proteins or other molecules.
- Recombinant proteins
- Proteins produced by genetically engineered organisms, used in research, diagnostics, and therapeutics.
- GMP
- Good Manufacturing Practice – a quality standard for pharmaceutical production to ensure safety and consistency.
- CRO
- Contract Research Organisation – a company that provides research services to the pharmaceutical or biotech industry.
The numbers around it
Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →
Other articles talking about it
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
All startup news on 11 March 2026 →
Is this Genexis Biotech? Get your “Featured on StopDown” badge →